Vitamin K and fractures
This article was originally published in The Tan Sheet
Executive SummaryOral supplementation with vitamin K (phytonadione and menaquinone), especially vitamin K2 (menaquinone-4), is linked to increased bone mineral density and reduced fractures, according to a systematic review and meta-analysis published in the Archives of Internal Medicine June 26. The meta-analysis assess data from seven randomized controlled trials and found a "striking" 80% reduction in hip fractures with vitamin K supplementation, Sarah Cockayne, University of York, England, et al., state. "Our findings should be treated cautiously, however, because the studies were not primarily designed to show a fracture effect," they explain. The results of the meta-analysis and review suggest that people susceptible to fracture should eat a diet that is rich in vitamin K, "which is chiefly obtained from green leafy vegetables and certain vegetable oils," the study authors say...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.